Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2008

Open Access 01-12-2008 | Research article

Mechanism of HIV protein induced modulation of mesenchymal stem cell osteogenic differentiation

Authors: Eoin J Cotter, Herbert Shi Ming Ip, William G Powderly, Peter P Doran

Published in: BMC Musculoskeletal Disorders | Issue 1/2008

Login to get access

Abstract

Background

A high incidence of decreased bone mineral density (BMD) has been associated with HIV infection. Normal skeletal homeostasis is controlled, at least in part, by the maturation and activity of mature osteoblasts. Previous studies by our group have demonstrated the ability of HIV proteins to perturb osteoblast function, and the degree of osteogenesis in differentiating mesenchymal stem cells (MSCs). This study attempts to further dissect the dynamics of this effect.

Methods

MSCs were cultured under both osteogenic (cultured in commercially available differentiation media) and quiescent (cultured in basal medium) conditions. Both cell populations were exposed to HIV p55-gag and HIV rev (100 ng/ml). Time points were taken at 3, 6, 9, and 15 days for osteogenic conditions, while quiescent cells were treated for 1 week. Cell function (alkaline phosphatase [ALP] activity, calcium deposition, and lipid levels) and the activity of the key MSC transcription factors, RUNX-2 and PPARgamma were determined post-exposure. Also, in cells cultured in differentiating conditions, cellular levels of connective tissue growth factor (CTGF) were analysed using whole cell ELISA, while BMP-2 secretion was also examined.

Results

In differentiating MSCs, exposure to HIV proteins caused significant changes in both the timing and magnitude of key osteogenic events and signals. Treatment with REV increased the overall rate of mineralization, and induced earlier increases in CTGF levels, RUNX-2 activity and BMP-2 secretion, than those observed in the normal course of differntiation. In contrast, p55-gag reduced the overall level of osteogenesis, and reduced BMP-2 secretion, RUNX-2 activity, CTGF levels and ALP activity at many of the timepoints examined. Finally, in cells cultured in basal conditions, treatment with HIV proteins did not in and of itself induce a significant degree of differentiation over the time period examined.

Conclusion

These data demonstrate that the effect of HIV proteins on bone is dependent on the differentiation status of the cells that they are in contact with. The effect on bone cell signalling provides insights into the mechanism of HIV induced decreases in bone mineral density.
Appendix
Available only for authorised users
Literature
1.
go back to reference Allison GT, Bostrom MP, Glesby MJ: Osteonecrosis in HIV disease: epidemiology, etiologies and clinical management. AIDS. 2003, 17: 1-9. 10.1097/00002030-200301030-00003.CrossRefPubMed Allison GT, Bostrom MP, Glesby MJ: Osteonecrosis in HIV disease: epidemiology, etiologies and clinical management. AIDS. 2003, 17: 1-9. 10.1097/00002030-200301030-00003.CrossRefPubMed
2.
go back to reference Thomas J, Doherty SM: HIV infection--a risk factor for osteoporosis. J Acquir Immune Defic Syndr. 2003, 33: 281-291.CrossRefPubMed Thomas J, Doherty SM: HIV infection--a risk factor for osteoporosis. J Acquir Immune Defic Syndr. 2003, 33: 281-291.CrossRefPubMed
3.
go back to reference Powderly WG: Long term exposure to lifelong therapies. J Acquir Immune Defic Syndr. 2002, 29 (Suppl 1): S28-S40.CrossRefPubMed Powderly WG: Long term exposure to lifelong therapies. J Acquir Immune Defic Syndr. 2002, 29 (Suppl 1): S28-S40.CrossRefPubMed
4.
go back to reference McDermot A, Shevitz A, Knox T, Roubenoff R, Kehayias J, Gorbach S: Effect of highly active antiretroviral therapy on fat, lean and bone mass in HIV-seropositive men and women. Am J Clin Nutr. 2001, 74: 679-86. McDermot A, Shevitz A, Knox T, Roubenoff R, Kehayias J, Gorbach S: Effect of highly active antiretroviral therapy on fat, lean and bone mass in HIV-seropositive men and women. Am J Clin Nutr. 2001, 74: 679-86.
5.
go back to reference Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE: Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS. 2000, 14: 63-67. 10.1097/00002030-200003100-00005.CrossRef Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE: Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS. 2000, 14: 63-67. 10.1097/00002030-200003100-00005.CrossRef
6.
go back to reference Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P: Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus infected individuals. Clin Infect Dis. 2003, 36: 482-490. 10.1086/367569.CrossRefPubMed Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P: Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus infected individuals. Clin Infect Dis. 2003, 36: 482-490. 10.1086/367569.CrossRefPubMed
7.
go back to reference Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK, 903 Study Group: Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004, 292: 191-201. 10.1001/jama.292.2.191.CrossRefPubMed Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK, 903 Study Group: Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004, 292: 191-201. 10.1001/jama.292.2.191.CrossRefPubMed
8.
go back to reference Overton Et, Mondy K, Bush T, Conley L, Kojic E, Henry K, Hammer J, Wood K, Lichtenstein K, Brooks J, SUN Study Investigators: Factors associated with low bone mineral density in a large cohort of HIV-infected US adults: baseline results from the SUN study. Program and abstracts of the 14th Conference on Retroviruses and Opportunistic Infections Abstract 836. Los Angeles, California, February 25–28, 2007 Overton Et, Mondy K, Bush T, Conley L, Kojic E, Henry K, Hammer J, Wood K, Lichtenstein K, Brooks J, SUN Study Investigators: Factors associated with low bone mineral density in a large cohort of HIV-infected US adults: baseline results from the SUN study. Program and abstracts of the 14th Conference on Retroviruses and Opportunistic Infections Abstract 836. Los Angeles, California, February 25–28, 2007
9.
go back to reference Wang MWH, Wei S, Faccio R, Takeshita S, Tebas P, Powderly WG, Teitelbaum SL, Ross FP: The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signalling. J Clin Invest. 2004, 114: 206-213.CrossRefPubMedPubMedCentral Wang MWH, Wei S, Faccio R, Takeshita S, Tebas P, Powderly WG, Teitelbaum SL, Ross FP: The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signalling. J Clin Invest. 2004, 114: 206-213.CrossRefPubMedPubMedCentral
10.
go back to reference Serrano S, Marinoso ML, Soriano JC, Rubies-Prat J, Aubia J, Coll J, Bosch J, Del Rio L, Vila J, Goday A: Bone remodelling in Human Immunodeficiency Virus 1 Infected Patients. A histomorphometric Study. Bone. 1995, 29 (2): 185-191. 10.1016/8756-3282(94)00028-X.CrossRef Serrano S, Marinoso ML, Soriano JC, Rubies-Prat J, Aubia J, Coll J, Bosch J, Del Rio L, Vila J, Goday A: Bone remodelling in Human Immunodeficiency Virus 1 Infected Patients. A histomorphometric Study. Bone. 1995, 29 (2): 185-191. 10.1016/8756-3282(94)00028-X.CrossRef
11.
go back to reference Fakruddin JM, Laurence J: HIV envelope gp120-mediated Regulation of Osteoclastogenesis via Receptor Activator of Nuclear Factor κB Ligand (RANKL) Secretion and Its Modulation by Certain HIV Protease Inhibitors through Interferon-γ/RANKL Cross-talk. J Biol Chem. 2003, 278: 48251-48258. 10.1074/jbc.M304676200.CrossRefPubMed Fakruddin JM, Laurence J: HIV envelope gp120-mediated Regulation of Osteoclastogenesis via Receptor Activator of Nuclear Factor κB Ligand (RANKL) Secretion and Its Modulation by Certain HIV Protease Inhibitors through Interferon-γ/RANKL Cross-talk. J Biol Chem. 2003, 278: 48251-48258. 10.1074/jbc.M304676200.CrossRefPubMed
12.
go back to reference Pagani F, Francucci CM, Moro L: Markers of bone turnover: biochemical and clinical perspectives. J Endocrinol Invest. 2005, 28: 8-13.CrossRefPubMed Pagani F, Francucci CM, Moro L: Markers of bone turnover: biochemical and clinical perspectives. J Endocrinol Invest. 2005, 28: 8-13.CrossRefPubMed
13.
go back to reference Okada Y, Tanaka Y: Immune signals in the context of secondary osteoporosis. Histol Histopathol. 2004, 19: 863-866.PubMed Okada Y, Tanaka Y: Immune signals in the context of secondary osteoporosis. Histol Histopathol. 2004, 19: 863-866.PubMed
14.
go back to reference Mbalaviele G, Sheikh S, Stains JP, Salazar VS, Cheng SL, Chen D, Civitelli R: β-Catenin and BMP-2 synergise to promote osteoblast differentiation and new bone formation. Jour Cell Biochem. 2005, 94: 403-418. 10.1002/jcb.20253.CrossRef Mbalaviele G, Sheikh S, Stains JP, Salazar VS, Cheng SL, Chen D, Civitelli R: β-Catenin and BMP-2 synergise to promote osteoblast differentiation and new bone formation. Jour Cell Biochem. 2005, 94: 403-418. 10.1002/jcb.20253.CrossRef
15.
go back to reference Jeon EJ, Lee KL, Choi NS, Lee MH, Kim HN, Jin YH, Ryoo HM, Choi JY, Yoshida M, Nishino N, Oh BC, Lee KS, Lee YH, Bae SC: Bone Morphogenetic Protein-2 Stimulates RUNX2 Acetylation. J Biol Chem. 2006, 281: 16502-16511. 10.1074/jbc.M512494200.CrossRefPubMed Jeon EJ, Lee KL, Choi NS, Lee MH, Kim HN, Jin YH, Ryoo HM, Choi JY, Yoshida M, Nishino N, Oh BC, Lee KS, Lee YH, Bae SC: Bone Morphogenetic Protein-2 Stimulates RUNX2 Acetylation. J Biol Chem. 2006, 281: 16502-16511. 10.1074/jbc.M512494200.CrossRefPubMed
16.
go back to reference Tou L, Quibria N, Alexander JM: Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morophogenic protein-7. Molec Cell Endocrin. 2003, 205: 121-129. 10.1016/S0303-7207(03)00151-5.CrossRef Tou L, Quibria N, Alexander JM: Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morophogenic protein-7. Molec Cell Endocrin. 2003, 205: 121-129. 10.1016/S0303-7207(03)00151-5.CrossRef
17.
go back to reference Li YL, Xiao ZS: Advances in Runx2 regulation and its isoforms. Med Hypotheses. 2007, 68 (1): 169-75. 10.1016/j.mehy.2006.06.006.CrossRefPubMed Li YL, Xiao ZS: Advances in Runx2 regulation and its isoforms. Med Hypotheses. 2007, 68 (1): 169-75. 10.1016/j.mehy.2006.06.006.CrossRefPubMed
18.
go back to reference Caplan AI: Mesenchymal stem cells. J Ortho Res. 1991, 9: 641-650. 10.1002/jor.1100090504.CrossRef Caplan AI: Mesenchymal stem cells. J Ortho Res. 1991, 9: 641-650. 10.1002/jor.1100090504.CrossRef
19.
go back to reference Gregory CA, Prockop DJ, Spees JL: Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Exp Cell Res. 2005, 306: 330-335. 10.1016/j.yexcr.2005.03.018.CrossRefPubMed Gregory CA, Prockop DJ, Spees JL: Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Exp Cell Res. 2005, 306: 330-335. 10.1016/j.yexcr.2005.03.018.CrossRefPubMed
20.
go back to reference Nuttall ME, Gimble JM: Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol. 2004, 4: 290-294. 10.1016/j.coph.2004.03.002.CrossRefPubMed Nuttall ME, Gimble JM: Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol. 2004, 4: 290-294. 10.1016/j.coph.2004.03.002.CrossRefPubMed
21.
go back to reference Meunier P, Aaron J, Edouard C, Vignon G: Osteoporosis and the replacement of cell populations of the marrow by adipose tissue, A quantitative study of 84 iliac bone biopsies. Clin Orthop. 1971, 80: 147-154. 10.1097/00003086-197110000-00021.CrossRefPubMed Meunier P, Aaron J, Edouard C, Vignon G: Osteoporosis and the replacement of cell populations of the marrow by adipose tissue, A quantitative study of 84 iliac bone biopsies. Clin Orthop. 1971, 80: 147-154. 10.1097/00003086-197110000-00021.CrossRefPubMed
22.
go back to reference Luo Q, Kang Q, Weike S, Jiang W, Park JK, Peng Y, Li X, Luu HH, Luo J, Montag AG, Haydon RC, He TC: Connective tissue growth factor (CTGF) is regulated by Wnt and Bone Morphogenetic Proteins signalling in osetoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004, 279: 55958-55968. 10.1074/jbc.M407810200.CrossRefPubMed Luo Q, Kang Q, Weike S, Jiang W, Park JK, Peng Y, Li X, Luu HH, Luo J, Montag AG, Haydon RC, He TC: Connective tissue growth factor (CTGF) is regulated by Wnt and Bone Morphogenetic Proteins signalling in osetoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004, 279: 55958-55968. 10.1074/jbc.M407810200.CrossRefPubMed
23.
go back to reference Kulterer B, Friedl G, Jandrositz A, Sanchez-Cabo F, Prokesch A, Paar C, Scheideler M, Windhager R, Preisegger KH, Trajanoski Z: Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics. 8: 70-10.1186/1471-2164-8-70. 2007 Mar 12 Kulterer B, Friedl G, Jandrositz A, Sanchez-Cabo F, Prokesch A, Paar C, Scheideler M, Windhager R, Preisegger KH, Trajanoski Z: Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics. 8: 70-10.1186/1471-2164-8-70. 2007 Mar 12
24.
go back to reference Cotter EJ, Malizia AP, Chew N, Powderly WG, Doran PP: HIV proteins regulate bone marker secretion and transcription factor activity in cultured human osteoblasts with consequent potential implications for osteoblast function and development. AIDS Res Hum Retroviruses. 2007, 23 (12): 1521-1530. 10.1089/aid.2007.0112.CrossRefPubMed Cotter EJ, Malizia AP, Chew N, Powderly WG, Doran PP: HIV proteins regulate bone marker secretion and transcription factor activity in cultured human osteoblasts with consequent potential implications for osteoblast function and development. AIDS Res Hum Retroviruses. 2007, 23 (12): 1521-1530. 10.1089/aid.2007.0112.CrossRefPubMed
26.
go back to reference Singh N, Kumar S, Singh P, Raj HG, Prasad AK, Parmar VS, Ghosh B: Piper longum Linn. Extract inhibits TNF-alpha-induced expression of cell adhesion molecules by inhibiting NF-kappaB activation and microsomal lipid peroxidation. Phytomedicine. 2008, 15: 284-291. 10.1016/j.phymed.2007.06.007.CrossRefPubMed Singh N, Kumar S, Singh P, Raj HG, Prasad AK, Parmar VS, Ghosh B: Piper longum Linn. Extract inhibits TNF-alpha-induced expression of cell adhesion molecules by inhibiting NF-kappaB activation and microsomal lipid peroxidation. Phytomedicine. 2008, 15: 284-291. 10.1016/j.phymed.2007.06.007.CrossRefPubMed
27.
go back to reference Dammeier J, Beer HD, Brauchle M, Werner S: Dexamethasone is a novel potent inducer of connective tissue growth factor expression. J Biol Chem. 1998, 273: 18185-18190. 10.1074/jbc.273.29.18185.CrossRefPubMed Dammeier J, Beer HD, Brauchle M, Werner S: Dexamethasone is a novel potent inducer of connective tissue growth factor expression. J Biol Chem. 1998, 273: 18185-18190. 10.1074/jbc.273.29.18185.CrossRefPubMed
28.
go back to reference Wickert L, Chatain N, Kruschinsky K, Gressner AM: Gluticorticoids activate TGF-β induced PAI-1 and CTGF expression in rat hepatocytes. Comparative Hepatology. 2007, 6: 5-10.1186/1476-5926-6-5.CrossRefPubMedPubMedCentral Wickert L, Chatain N, Kruschinsky K, Gressner AM: Gluticorticoids activate TGF-β induced PAI-1 and CTGF expression in rat hepatocytes. Comparative Hepatology. 2007, 6: 5-10.1186/1476-5926-6-5.CrossRefPubMedPubMedCentral
29.
go back to reference Geoffry V, Kniessel M, Fournier B, Boyde A, Matthias P: High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol Cell Biol. 2002, 22: 6222-6233. 10.1128/MCB.22.17.6222-6233.2002.CrossRef Geoffry V, Kniessel M, Fournier B, Boyde A, Matthias P: High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol Cell Biol. 2002, 22: 6222-6233. 10.1128/MCB.22.17.6222-6233.2002.CrossRef
30.
go back to reference Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C: Canonical wnt/β-catenin signalling prevents osteoblasts from differentiating into chondrocytes. Dev Cell. 2005, 8: 727-738. 10.1016/j.devcel.2005.02.013.CrossRefPubMed Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C: Canonical wnt/β-catenin signalling prevents osteoblasts from differentiating into chondrocytes. Dev Cell. 2005, 8: 727-738. 10.1016/j.devcel.2005.02.013.CrossRefPubMed
31.
go back to reference Kang S, Bennett CN, Gerin I, Rapp LA, Hankenson KD, Macdougald OA: Wnt signalling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/Enhancer-binding protein α and peroxisome proliferator-activated receptor γ. J Biol Chem. 2007, 282: 14515-14524. 10.1074/jbc.M700030200.CrossRefPubMed Kang S, Bennett CN, Gerin I, Rapp LA, Hankenson KD, Macdougald OA: Wnt signalling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/Enhancer-binding protein α and peroxisome proliferator-activated receptor γ. J Biol Chem. 2007, 282: 14515-14524. 10.1074/jbc.M700030200.CrossRefPubMed
32.
go back to reference Wang L, Mondal D, La Russa VF, Agrawal KC: Suppression of Clonogenic Potential of Human Bone Marrow Mesenchymal Stem Cells by HIV Type 1: Putative Role of HIV Type 1 Tat Protein and Inflamatory Cytokines. AIDS Res Hum Retroviruses. 2002, 18 (13): 917-931. 10.1089/088922202760265597.CrossRefPubMed Wang L, Mondal D, La Russa VF, Agrawal KC: Suppression of Clonogenic Potential of Human Bone Marrow Mesenchymal Stem Cells by HIV Type 1: Putative Role of HIV Type 1 Tat Protein and Inflamatory Cytokines. AIDS Res Hum Retroviruses. 2002, 18 (13): 917-931. 10.1089/088922202760265597.CrossRefPubMed
33.
go back to reference Scadden DT: Stem cells and immune reconstitution in AIDS. Blood Reviews. 2003, 17: 227-231. 10.1016/S0268-960X(03)00021-3.CrossRefPubMed Scadden DT: Stem cells and immune reconstitution in AIDS. Blood Reviews. 2003, 17: 227-231. 10.1016/S0268-960X(03)00021-3.CrossRefPubMed
34.
go back to reference Schwartz GN, Kessler SW, Szabo JM, Burrell LM, Francis ML: Negative regulators may mediate some of the inhibitory effects of HIV-1 infected stromal cell layers on erythropoiesis and myelopoiesis in human bone marrow long term cutures. J Leukoc Biol. 1995, 57 (6): 948-55.PubMed Schwartz GN, Kessler SW, Szabo JM, Burrell LM, Francis ML: Negative regulators may mediate some of the inhibitory effects of HIV-1 infected stromal cell layers on erythropoiesis and myelopoiesis in human bone marrow long term cutures. J Leukoc Biol. 1995, 57 (6): 948-55.PubMed
Metadata
Title
Mechanism of HIV protein induced modulation of mesenchymal stem cell osteogenic differentiation
Authors
Eoin J Cotter
Herbert Shi Ming Ip
William G Powderly
Peter P Doran
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2008
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-9-33

Other articles of this Issue 1/2008

BMC Musculoskeletal Disorders 1/2008 Go to the issue